Digital asset valuations hold firm as institutional investors digest the latest security incident at Binance, signaling growing market maturity.

Reporting on market developments concerning I Tested Another Airport VIP Service, This Time in Rome. Industry analysts and investors are monitoring the operational, strategic, and ...

Eli Lilly posted robust quarterly financial results driven by flagship injectables, though clinical nuances in its oral obesity pipeline tempered investor enthusiasm.

Cuauhtémoc Cárdenas, the political titan whose historic 1988 presidential campaign broke Mexico's one-party rule, has passed away at the age of 92.

A dramatic five-day crisis has sent shockwaves through the corporate legal sector, testing institutional governance and partner stability across top-tier advisory firms.

Behind exhilarating postseason races lies an escalating financial divide, as regional sports network bankruptcies and widening payroll disparities push baseball toward structural upheaval.

As proposals targeting unrealized capital gains gain political traction, high-net-worth investors and business leaders are countering with alternative tax reform frameworks.

A prolonged housing slowdown and softening pulp demand trigger fresh sawmill closures across the U.S. South, trapping pine growers in an acute oversupply glut.

Eli Lilly posted significant revenue gains driven by unprecedented global demand for its blockbuster treatments Mounjaro and Zepbound, solidifying its leadership in the metabolic therapeutics market.

Merck posted robust top-line gains driven by enduring demand for blockbuster oncology drug Keytruda and rapid market adoption of newly launched Winrevair.

Japanese government bond yields advanced across the curve as fixed-income desks positioned defensively ahead of a critical Bank of Japan policy meeting.

Samsung Electronics posted historic quarterly profits, driven by a fierce recovery in memory chips and surging global demand for artificial intelligence hardware.